DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia

被引：2

作者：

Kaito, Yuta ^{[1
]}

Sugimoto, Emi ^{[2
]}

Nakamura, Fumi ^{[3
]}

Tsukune, Yutaka ^{[4
]}

Sasaki, Makoto ^{[5
]}

Yui, Shunsuke ^{[6
]}

Yamaguchi, Hiroki ^{[6
]}

Goyama, Susumu ^{[7
]}

Nannya, Yasuhito ^{[1
]}

Mitani, Kinuko ^{[3
]}

Tamura, Hideto ^{[8
]}

Imai, Yoichi ^{[3
]}

机构：

[1] Univ Tokyo, IMSUT Hosp, Dept Hematol Oncol, Tokyo, Japan

[2] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan

[3] Dokkyo Med Univ, Dept Hematol & Oncol, Shimotsuga Dist, Tochigi, Japan

[4] Juntendo Univ, Sch Med, Dept Hematol, Tokyo, Japan

[5] Juntendo Univ, Sch Med, Div Hematol, Tokyo, Japan

[6] Nippon Med Sch, Dept Hematol, Tokyo, Japan

[7] Univ Tokyo, Grad Sch Frontier Sci, Div Mol Oncol, Tokyo, Japan

[8] Dokkyo Med Univ, Saitama Med Ctr, Dept Hematol, Koshigaya, Japan

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-164435

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4514 / 4516

页数：3

共 50 条

[41] CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Qingya Cui
Chongsheng Qian
Nan Xu
Liqing Kang
Haiping Dai
Wei Cui
Baoquan Song
Jia Yin
Zheng Li
Xiaming Zhu
Changju Qu
Tianhui Liu
Wenhong Shen
Mingqing Zhu
Lei Yu
Depei Wu
Xiaowen Tang
Journal of Hematology & Oncology, 14
[42] Ex Vivo IL-2 Expansion of CB-NK Cells Promotes Synergistic LFA-1 and CD2 Engagement at the NK Cell Lytic Immune Synapse; Implications for Adoptive CB-NK Cell Therapy in Acute Myeloid Leukemia.
Xing, Dongxia
Ramsay, Alan G.
Decker, William
Li, Sufang
Robinson, Simon
Yang, Hong
Bollard, Catherine M.
Gribben, John G.
Shpall, Elizabeth J.
BLOOD, 2009, 114 (22) : 1180 - 1181
[43] Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
Cuapio, Angelica
Post, Mirte
Cerny-Reiterer, Sabine
Gleixner, Karoline V.
Stefanzl, Gabriele
Basilio, Jose
Herndlhofer, Susanne
Sperr, Wolfgang R.
Brons, Nicolaas H. C.
Casanova, Emilio
Zimmer, Jacques
Valent, Peter
Hofer, Erhard
ONCOTARGET, 2016, 7 (29) : 46466 - 46481
[44] AFM28, a Novel Bispecific Innate Cell Engager (ICE ®), Designed to Selectively Re-Direct NK Cell Lysis to CD123+Leukemic Cells in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Goetz, Jana-Julia
Pahl, Jens
Schmitt, Nanni
Mueller, Thomas
Haneke, Torsten
Kozlowska, Izabela
Sarlang, Séverine
Knackmuss, Stefan
Peters, Eike
Reusch, Uwe
Ross, Thorsten
Nowak, Daniel
Hofmann, Wolf-Karsten
Merz, Christian
BLOOD, 2021, 138
[45] Novel bispecific innate cell engager AFM28 efficiently directs allogenic NK cells to CD123+leukemic blasts and stem cells in acute myeloid leukemia and myelodysplastic neoplasms
Schmitt, N.
Siegler, J. -J
Pahl, J.
Wagner, L.
Schulze, N.
Beck, A.
Haneke, T.
Reusch, U.
Medina-Echeverz, J.
Endell, J.
Hofmann, W-K
Ross, T.
Nowak, D.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 100 - 101
[46] Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T Cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy
Root, Jessica Lynn
Desai, Poonam N.
Reville, Patrick K.
Ly, Christopher
Wang, Bofei
Jelloul, Fatima Z.
Zhou, Jing
Mackay, Sean Gregory
Alfayez, Mansour
Matthews, Jairo
Pierce, Sherry
Daver, Naval
Abbas, Hussein A.
BLOOD, 2023, 142
[47] Clonal evolution from B-cell acute lymphoblastic leukemia with BCR::ABL1 multilineage involvement to acute myeloid leukemia after multiple anti-CD19 chimeric antigen receptor T-cell therapy
Liu, Mei-Jing
Dai, Lan
Yao, Li
Tan, Kai-Wen
Cao, Han-Yu
Huang, Si-Man
Wan, Chao-Ling
Huang, Yuan-Hong
Zhang, Yang
Gong, Wen-Jie
Xue, Sheng-Li
HAEMATOLOGICA, 2024, 109 (11) : 3821 - 3825
[48] SINGLE CELL PROFILING OF ACUTE MYELOID LEUKEMIA (AML) AND ITS MICROENVIRONMENT REVEALS A CD8 CONTINUUM AND ADAPTABLE T CELL PLASTICITY IN RESPONSE TO PD-1 BLOCKADE-BASED THERAPY
Abbas, Hussein
Hao, Dapeng
Tomczak, Katarzyna
Barrodia, Praveen
Im, Jin Seon
Reville, Patrick
Alaniz, Zoe
Wang, Wei
Wang, Ruiping
Wang, Feng
Al-Atrash, Gheath
Takahashi, Koichi
Ning, Jing
Ding, Maomao
Matthews, Jairo
Little, Latasha
Zhang, Jianhua
Basu, Sreyashi
Konopleva, Marina
Garcia-Manero, Guillermo
Green, Michael
Sharma, Padmanee
Allison, James
Kornblau, Steven
Rai, Kunal
Wang, Linghua
Daver, Naval
Futreal, Andrew
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A445 - A446
[49] First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial
Liu, Fang
Cao, Yuanzhen
Pinz, Kevin
Ma, Yu
Wada, Masayuki
Chen, Kevin
Ma, Gina
Shen, Jiaqi
Tse, Charlotte Olivia
Su, Yi
Xiong, Yisong
He, Guangcui
Li, Yecheng
Ma, Yupo
BLOOD, 2018, 132
[50] Single-cell profiling of acute myeloid leukemia (AML) and its microenvironment reveals a CD8 continuum and adaptable T cell plasticity in response to PD-1 blockade-based therapy.
Abbas, Hussein A.
Hao, Dapeng
Tomczak, Katarzyna
Barrodia, Praveen
Im, Jin Seon
Reville, Patrick K.
Al-Atrash, Gheath
Ning, Jing
Ding, Maomao
Mathews, Jairo T.
Little, Latasha
Zhang, Jianhua
Basu, Sreyashi
Konopleva, Marina
Garcia-Manero, Guillermo
Green, Michael R.
Sharma, Padmanee
Allison, James P.
Kornblau, Steven M.
Rai, Kunal
Wang, Linghua
Daver, Naval
Futreal, Andrew
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)

← 1 2 3 4 5 →